2024-03-05: Audited Annual Financial Statements of Asiatic Laboratories Limited

Asiatic Laboratories Limited: As per audited annual financial statements, profit after tax was BDT 268.56 million and Pre-IPO EPS of BDT 3.06 and Post IPO EPS was BDT 2.19 for the year ended on 30 June 2022. Pre-IPO Net Asset Value (NAV) per share with revaluation reserve was BDT 59.68 and NAV per share without revaluation reserve was BDT 38.61.